| Component: (Network and Table) | |
|---|---|
| Network | 00400 - Statement - Consolidated Statements Of Cash Flows (http://www.acadiahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows) |
| Table | (Implied) |
| Reporting Entity [Axis] | 0001520697 (http://www.sec.gov/CIK) |
| Consolidated Statements Of Cash Flows [Abstract] | Period [Axis] | ||
|---|---|---|---|
2011-01-01 - 2011-12-31 | 2010-01-01 - 2010-12-31 | 2009-01-01 - 2009-12-31 | |
Consolidated Statements Of Cash Flows [Abstract] | |||
Operating activities: | |||
Net (loss) income | (34,892,000) | 6,210,000 | 2,877,000 |
Adjustments to reconcile net (loss) income to net cash provided by continuing operating activities: | |||
Depreciation and amortization | 4,288,000 | 976,000 | 997,000 |
Provision for bad debts | 3,226,000 | 2,239,000 | 2,424,000 |
Amortization of debt issuance costs | 1,271,000 | ||
Equity-based compensation expense | 17,320,000 | ||
Deferred income tax expense | (6,442,000) | (145,000) | |
Other | (168,000) | ||
Loss (income) from discontinued operations, net of taxes | 2,019,000 | 471,000 | (119,000) |
Change in operating assets and liabilities, net of effect of acquisitions: | |||
Accounts receivable | (5,051,000) | (2,174,000) | (2,994,000) |
Other current assets | (1,635,000) | 35,000 | (1,215,000) |
Other assets | (969,000) | ||
Accounts payable and other accrued liabilities | 3,346,000 | 541,000 | 2,066,000 |
Accrued salaries and benefits | (1,654,000) | 187,000 | 1,369,000 |
Other liabilities | 734,000 | (250,000) | 644,000 |
Net cash (used in) provided by continuing operating activities | (18,607,000) | 8,090,000 | 6,049,000 |
Net cash (used in) provided by discontinued operating activities | (2,059,000) | 105,000 | 119,000 |
Net cash (used in) provided by operating activities | (20,666,000) | 8,195,000 | 6,168,000 |
Investing activities: | |||
Cash paid for acquisitions, net of cash acquired | (206,379,000) | (3,142,000) | |
Cash paid for capital expenditures | (9,558,000) | (1,495,000) | (334,000) |
Cash paid for real estate acquisitions | (8,706,000) | ||
Other | (689,000) | ||
Net cash used in continuing investing activities | (225,332,000) | (1,495,000) | (3,476,000) |
Net cash (used in) provided by discontinued investing activities | (238,000) | (3,000) | 65,000 |
Net cash used in investing activities | (225,570,000) | (1,498,000) | (3,411,000) |
Financing activities: | |||
Borrowings on long-term debt | 282,485,000 | ||
Principal payments on long-term debt | (5,063,000) | (275,000) | (813,000) |
Repayment of long-term debt | (9,984,000) | ||
Payment of debt issuance costs | (12,111,000) | ||
Proceeds from stock option exercises | 38,000 | ||
Proceeds from issuance of common stock | 68,059,000 | ||
Payment of equity issuance costs | (897,000) | ||
Cash distribution paid to equity holders | (74,441,000) | ||
Contribution from Holdings | 51,029,000 | 2,500,000 | |
Distributions to equity holders | (375,000) | (2,297,000) | |
Net cash provided by (used in) financing activities | 298,740,000 | (2,572,000) | 1,687,000 |
Net increase in cash and cash equivalents | 52,504,000 | 4,125,000 | 4,444,000 |
Cash and cash equivalents at beginning of the period | 8,614,000 | 4,489,000 | 45,000 |
Cash and cash equivalents at end of the period | 61,118,000 | 8,614,000 | 4,489,000 |
Supplemental Cash Flow Information: | |||
Cash paid for interest | 5,053,000 | 587,000 | 534,000 |
Cash paid for income taxes | 2,564,000 | 700,000 | 30,000 |
Significant Non-Cash Transactions: | |||
Issuance of common stock in connection with acquisition | 44,025,000 | ||
Issuance of replacement share-based awards in connection with acquisition | 1,027,000 | ||
Effect of acquisitions: | |||
Assets acquired, excluding cash | 278,895,000 | 3,142,000 | |
Liabilities assumed | (27,464,000) | ||
Issuance of common stock in connection with acquisition | (44,025,000) | ||
Issuance of replacement share-based awards in connection with acquisition | (1,027,000) | ||
Cash paid for acquisitions, net of cash acquired | 206,379,000 | 3,142,000 | |